Viatris Picks Brand-Recognized R&D Head To Fuel Novel Ambitions

Philippe Martin Familiar To CEO Smith; CFO Sanjeev Narula Also To Step Down

Viatris CEO Scott Smith is to work alongside an exec from not one but two of his former employers, after Philippe Martin was appointed to head up R&D at the firm and drive its ambitions in the novel space.

R&D
• Source: Alamy

Viatris will look to tap the novel brands expertise of Philippe Martin after appointing the former Celgene and Schering-Plough exec as the company’s chief R&D officer with immediate effect, marking yet another step in its recent structural efforts to pivot from off-patent products and move up the value chain to innovative products.

“As chief R&D officer, Martin brings with him significant innovative product development experience across R&D, scientific and regulatory affairs,” Viatris...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

Wagner Adds Germany To Role As Stada Simplifies Structure

Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.

ADHD

This is regarding ADHD.

test

More from Generics Bulletin

GB-Business-Free-Podcast-The Secret to Walking More: It’s Not Counting Steps - Clone

 
• By 

We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.